Clinical trial
Evaluating the Effectiveness of Chatbot-Based Intervention on Enhancing Self-management and Decision Self-efficacy Among Men Having Lower Urinary Tract Symptoms With or Without Erectile Dysfunction in the Post COVID-19 Era
NCT05765331 is registered in ClinicalTrials.gov with Cheng-Hsin General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluating the Effectiveness of Chatbot-Based Intervention on Enhancing Self-management and Decision Self-efficacy Among Men Having Lower Urinary Tract Symptoms With or Without Erectile Dysfunction in the Post COVID-19 Era
- Lead sponsor
- Cheng-Hsin General Hospital
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- January 2, 2023
- Completion date
- December 31, 2023
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
benign prostate enlargement, erectile dysfunction, lower urinary tract symptoms